Targeting Toll-Like Receptors for Cancer Therapy

Targeted Oncology
Marc J BraunsteinSylvia Adams

Abstract

The immune system encompasses a broad array of defense mechanisms against foreign threats, including invading pathogens and transformed neoplastic cells. Toll-like receptors (TLRs) are critically involved in innate immunity, serving as pattern recognition receptors whose stimulation leads to additional innate and adaptive immune responses. Malignant cells exploit the natural immunomodulatory functions of TLRs, expressed mainly by infiltrating immune cells but also aberrantly by tumor cells, to foster their survival, invasion, and evasion of anti-tumor immune responses. An extensive body of research has demonstrated context-specific roles for TLR activation in different malignancies, promoting disease progression in certain instances while limiting cancer growth in others. Despite these conflicting roles, TLR agonists have established therapeutic benefits as anti-cancer agents that activate immune cells in the tumor microenvironment and facilitate the expression of cytokines that allow for infiltration of anti-tumor lymphocytes and the suppression of oncogenic signaling pathways. This review focuses on the clinical application of TLR agonists for cancer treatment. We also highlight agents that are undergoing development in clini...Continue Reading

References

May 7, 1992·Nature·C O Starnes
Mar 7, 2001·Lancet·F Balkwill, A Mantovani
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Aug 13, 2003·The Journal of Urology·Andreas Böhle, Sven Brandau
Jan 7, 2004·Nature Reviews. Cancer·Jeffrey W Pollard
Jan 31, 2004·Seminars in Immunology·Kiyoshi Takeda, Shizuo Akira
Aug 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Francesca PalamaraMaria Sibilia
Aug 27, 2004·Nature·Eli PikarskyYinon Ben-Neriah
Sep 24, 2004·Nature·Fran Balkwill, Lisa M Coussens
Jun 17, 2005·Cancer Research·Bo HuangHuabao Xiong
Oct 26, 2005·Nature Medicine·Dianhua JiangPaul W Noble
Feb 14, 2006·Seminars in Immunology·Rong-Fu WangHelen Y Wang
Feb 25, 2006·Cell·Shizuo AkiraOsamu Takeuchi
Oct 13, 2006·Immunology·Andrea BroadUNKNOWN Applied Immunology and Transplantation Research Group
May 4, 2007·The Journal of Clinical Investigation·Arthur M Krieg
Jul 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Vincenzo DamianoGiampaolo Tortora
Dec 7, 2007·Gastroenterology·Masayuki FukataMaria T Abreu
Jun 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sylvia AdamsNina Bhardwaj
Jul 18, 2008·Nature Reviews. Cancer·Craig MurdochClaire E Lewis
Aug 30, 2008·International Journal of Cancer. Journal International Du Cancer·Victoria L StevensCarmen Rodriguez
Dec 5, 2008·Nature Reviews. Cancer·Seth Rakoff-Nahoum, Ruslan Medzhitov
Dec 18, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Johannes KluweRobert F Schwabe
Jun 27, 2009·Nature Reviews. Immunology·Gregory M Barton, Jonathan C Kagan
Dec 25, 2009·Current Pharmaceutical Design·T Matijevic, J Pavelic
Mar 3, 2010·Annual Review of Immunology·Gary P SimsAnthony J Coyle

❮ Previous
Next ❯

Citations

Feb 26, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nathaniel J ButeynSusheela Tridandapani
May 27, 2020·Acta Pharmacologica Sinica·Simon Van Herck, Bruno G De Geest
Jan 9, 2019·Frontiers in Immunology·Nataschja I HoGosse J Adema
Jul 16, 2020·Cancers·Eline JanssenDaniele V F Tauriello
Aug 6, 2020·International Journal of Molecular Sciences·Karim Pérez-RomeroDaniel H Lopez
Apr 25, 2020·Experimental Biology and Medicine·Sheng-Fan WangHsin-Chen Lee
Dec 2, 2020·Materials Science & Engineering. C, Materials for Biological Applications·José Manuel Gutiérrez-HernándezDiana María Escobar-García
Jan 17, 2021·Scientific Reports·Yinwen ChengAndrean L Simons
Dec 20, 2020·Nature Reviews. Rheumatology·Simon FillatreauThomas Dörner
Jan 21, 2021·Frontiers in Cell and Developmental Biology·Lin CuiDekai Zhang
Oct 17, 2020·Journal for Immunotherapy of Cancer·Yinwen ChengAndrean L Simons
Dec 17, 2020·International Journal of Molecular Sciences·Antonino Di LorenzoLaura Conti
Mar 9, 2021·Expert Opinion on Drug Discovery·Xuan HuangMengji Lu
Apr 27, 2021·Bioactive Materials·Komal AbhangeYuan Wan
Apr 21, 2021·Seminars in Cell & Developmental Biology·Deepti SinghHifzur R Siddique
Feb 12, 2021·Cancer Science·Sho HangaiHideyuki Yanai
May 4, 2021·The Journal of Clinical Investigation·Timothy P Lippert, Roger A Greenberg
May 26, 2021·JCI Insight·Luciana R Muniz-BongersNina Bhardwaj
Jun 26, 2021·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Qiankun LiangGuopan Wang
Aug 7, 2021·RSC Medicinal Chemistry·Deepender KaushikDeepak B Salunke
Jun 9, 2020·Bioconjugate Chemistry·Michel J van de GraaffSander I van Kasteren
Aug 23, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cao Dai PhungJong Oh Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.